Colorectal Cancer Microsatellite Stable (MSS)
2 clinical trials · Condition
◉ Watch Colorectal Cancer Microsatellite Stable (MSS)
| Record | Firm | Date |
|---|---|---|
| A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. (NCT03549000) | Novartis Pharmaceuticals | 2018-07-18 |
Track Colorectal Cancer Microsatellite Stable (MSS) automatically
Every clearance here is in the API, with alerts when new ones post.